Outset Medical, Inc. OM
Institutional shares held
19.9 Million
66.8K
calls
60.3K
puts
Total value of holdings
$17.9M
$60K
calls
$54K
puts
Market Cap
$43.7M
48,007,300
Shares Out.
Institutional ownership
41.41%
# of Institutions
91
We take great care to ensure that the data presented and summarized in this overview for Outset Medical, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding OM
View all-
Vanguard Group Inc Valley Forge, PA2.64MShares$2.41 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.89MShares$1.72 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.81MShares$1.65 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA1.47MShares$1.34 Million0.04% of portfolio
-
Ensign Peak Advisors, Inc Salt Lake City, UT1.39MShares$1.26 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.3MShares$1.19 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.18MShares$1.08 Million0.0% of portfolio
-
Gsa Capital Partners LLP London, X01.11MShares$1.01 Million0.06% of portfolio
-
C World Wide Group Holding A1MShares$910,0000.01% of portfolio
-
Black Rock Inc. New York, NY880KShares$801,2200.0% of portfolio
Latest Institutional Activity in OM
Top Purchases
Top Sells
About OM
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Insider Transactions at OM
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 15
2024
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
3,203
-1.39%
|
$0
$0.8 P/Share
|
|
Nov 15
2024
|
Marc Nash SVP Operations and R&D |
SELL
Open market or private sale
|
Direct |
1,375
-0.57%
|
$0
$0.8 P/Share
|
|
Nov 15
2024
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
5,645
-0.62%
|
$0
$0.8 P/Share
|
|
Nov 15
2024
|
Nabeel Ahmed Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,221
-1.34%
|
$0
$0.8 P/Share
|
|
Aug 15
2024
|
Marc Nash SVP Operations and R&D |
SELL
Open market or private sale
|
Direct |
1,293
-0.54%
|
$0
$0.84 P/Share
|
|
Aug 15
2024
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
5,308
-0.58%
|
$0
$0.84 P/Share
|
|
Aug 15
2024
|
Nabeel Ahmed Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,971
-1.25%
|
$0
$0.84 P/Share
|
|
Aug 15
2024
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
3,011
-1.29%
|
$0
$0.84 P/Share
|
|
Jul 24
2024
|
Marc Nash SVP Operations and R&D |
SELL
Open market or private sale
|
Direct |
723
-0.3%
|
$2,892
$4.02 P/Share
|
|
Jun 12
2024
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
10,569
-4.33%
|
$42,276
$4.78 P/Share
|
|
Jun 03
2024
|
D Keith Grossman Director |
SELL
Open market or private sale
|
Direct |
38,117
-24.63%
|
$114,351
$3.77 P/Share
|
|
Jun 03
2024
|
D Keith Grossman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
69,303
+30.18%
|
$69,303
$1.11 P/Share
|
|
May 29
2024
|
Dale E Jones Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+35.25%
|
-
|
|
May 29
2024
|
Brent D. Lang Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+15.82%
|
-
|
|
May 29
2024
|
Andrea Lynn Saia Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+34.3%
|
-
|
|
May 29
2024
|
Patrick T Hackett Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+36.85%
|
-
|
|
May 29
2024
|
James F. Hinrichs Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+23.73%
|
-
|
|
May 29
2024
|
Karen Drexler Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+34.14%
|
-
|
|
May 29
2024
|
D Keith Grossman Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+36.85%
|
-
|
|
May 16
2024
|
Nabeel Ahmed Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,918
-1.21%
|
$11,754
$3.53 P/Share
|
Last 12 Months Summary
Buy / Acquisition
2.03M
Shares
From
16
Insiders
| Grant, award, or other acquisition | 1.96M shares |
|---|---|
| Other acquisition or disposition | 1.58K shares |
| Exercise of conversion of derivative security | 69.3K shares |
Sell / Disposition
240K
Shares
From
10
Insiders
| Payment of exercise price or tax liability | 56.2K shares |
|---|---|
| Open market or private sale | 183K shares |